Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy and is associated with a number of potential outcomes, including impaired diastolic function, heart failure, and sudden cardiac death. Various etiologies have been described for HCM, including pressure overload and mu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Sasagawa, Shota, Nishimura, Yuhei, Okabe, Shiko, Murakami, Soichiro, Ashikawa, Yoshifumi, Yuge, Mizuki, Kawaguchi, Koki, Kawase, Reiko, Okamoto, Ryuji, Ito, Masaaki, Tanaka, Toshio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2016
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905960/
https://ncbi.nlm.nih.gov/pubmed/27378925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00162
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi